Prevent TB: Choice Architecture for TPT Delivery

Launched by JOHNS HOPKINS UNIVERSITY · Jul 7, 2020

Keywords

ClinConnect Summary

This clinical trial, titled "Prevent TB: Choice Architecture for TPT Delivery," is focused on improving the way we provide tuberculosis (TB) preventive therapy (TPT) for people living with HIV. Currently, less than 20% of eligible individuals receive this important treatment, which can significantly reduce the risk of TB, a leading cause of death among people with HIV. The study aims to find a better way to ensure more patients are offered TPT by changing how doctors decide to prescribe it, making TPT the standard option unless they choose not to prescribe it for a specific patient.

If you or someone you know is an adult (18 years or older) starting or continuing HIV treatment, you may be eligible to participate in this trial. Participants can expect to be part of a clinic that will either continue with current practices or switch to a new approach that encourages more TPT prescribing. The goal is to see if this new method can increase the number of patients screened for TPT, found eligible, and ultimately prescribed the treatment. This research is important because it seeks to save lives by ensuring that more people at risk for TB get the preventive care they need.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult (≥18 years old) patients initiating ART
• • Adult (≥18 years old) patients already on ART and coming for ART re-prescribing
• Exclusion Criteria:
• • None